Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
BACKGROUND: There is very limited data on the experience and outcome of multidrug-resistant tuberculosis (MDR-TB) patients treated privately out of the DOTS plus program. Goal of this study is to provide characteristics and treatment outcomes of a prospective cohort of MDR-TB patients managed at a p...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220314/ https://www.ncbi.nlm.nih.gov/pubmed/25378840 http://dx.doi.org/10.4103/0970-2113.142101 |
_version_ | 1782342712521916416 |
---|---|
author | Udwadia, Zarir F. Moharil, Gautam |
author_facet | Udwadia, Zarir F. Moharil, Gautam |
author_sort | Udwadia, Zarir F. |
collection | PubMed |
description | BACKGROUND: There is very limited data on the experience and outcome of multidrug-resistant tuberculosis (MDR-TB) patients treated privately out of the DOTS plus program. Goal of this study is to provide characteristics and treatment outcomes of a prospective cohort of MDR-TB patients managed at a private tertiary referral institute. MATERIALS AND METHODS: A prospective analysis of a cohort of MDR-TB patients treated in a tertiary private hospital, with the back-up of a Level 2 mycobacterial laboratory, which has recently received recognition by the Revised National Tuberculosis Control Program (RNTCP) for second-line drug susceptibility (DST). All patients received an individualized MDR regimen on an ambulatory basis. RESULTS: Our 68% success rates are respectable and show that given the right laboratory backing, MDR-TB can be managed successfully in selected private practice settings. |
format | Online Article Text |
id | pubmed-4220314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42203142014-11-06 Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai Udwadia, Zarir F. Moharil, Gautam Lung India Original Article BACKGROUND: There is very limited data on the experience and outcome of multidrug-resistant tuberculosis (MDR-TB) patients treated privately out of the DOTS plus program. Goal of this study is to provide characteristics and treatment outcomes of a prospective cohort of MDR-TB patients managed at a private tertiary referral institute. MATERIALS AND METHODS: A prospective analysis of a cohort of MDR-TB patients treated in a tertiary private hospital, with the back-up of a Level 2 mycobacterial laboratory, which has recently received recognition by the Revised National Tuberculosis Control Program (RNTCP) for second-line drug susceptibility (DST). All patients received an individualized MDR regimen on an ambulatory basis. RESULTS: Our 68% success rates are respectable and show that given the right laboratory backing, MDR-TB can be managed successfully in selected private practice settings. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4220314/ /pubmed/25378840 http://dx.doi.org/10.4103/0970-2113.142101 Text en Copyright: © Lung India http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Udwadia, Zarir F. Moharil, Gautam Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai |
title | Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai |
title_full | Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai |
title_fullStr | Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai |
title_full_unstemmed | Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai |
title_short | Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai |
title_sort | multidrug-resistant-tuberculosis treatment in the indian private sector: results from a tertiary referral private hospital in mumbai |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220314/ https://www.ncbi.nlm.nih.gov/pubmed/25378840 http://dx.doi.org/10.4103/0970-2113.142101 |
work_keys_str_mv | AT udwadiazarirf multidrugresistanttuberculosistreatmentintheindianprivatesectorresultsfromatertiaryreferralprivatehospitalinmumbai AT moharilgautam multidrugresistanttuberculosistreatmentintheindianprivatesectorresultsfromatertiaryreferralprivatehospitalinmumbai |